Toxicity, clearance, and metabolic effects of pactamycin in combination with bacterial lipopolysaccharide.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001806:Blood Urea Nitrogen; D004357:Drug Synergism; D004926:Escherichia coli / Q000378:metabolism; D007928:Lethal Dose 50; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008168:Lung / Q000378:metabolism; D008247:Lysosomes / Q000187:drug effects; D008297:Male; D008657:Metabolic Clearance Rate; D051379:Mice; D008807:Mice, Inbred BALB C; D009929:Organ Size; D010142:Pactamycin / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D012475:Salmonella
D000903:Antibiotics, Antineoplastic; D008070:Lipopolysaccharides; D010142:Pactamycin